case_images: PMC8046561_01
case_images: Liver MRI: demonstrates several liver lesions (segments 1, 3, 4, 7). These lesions were new compared to the liver MRI five years ago. One lesion in segment 3 and one lesion in segment 1 were new compared to the MRI scan of one month ago.
case_images: CRIS2021-6676109.001.jpg
case_images: PMC8046561_01_CRIS2021-6676109.001.jpg
case_images: fig1
case_images: Subsequently, contrast-enhanced MRI of the liver was performed which showed seven lesions suspect for metastatic disease (Figure 1).
case_images: Liver MRI one month earlier demonstrated only one lesion in segment 3 and no lesion in segment 1.
case_images: CRIS2021-6676109.002.jpg
case_images: PMC8046561_01_CRIS2021-6676109.002.jpg
case_images: fig2
case_images: In addition, two lesions were new compared to the MRI performed one month earlier in another hospital (Figure 2).
case_images: PMC8046561_02
case_images: Liver CT demonstrated the onset of seven liver lesions suspect for metastatic disease.
case_images: CRIS2021-6676109.003.jpg
case_images: PMC8046561_02_CRIS2021-6676109.003.jpg
case_images: fig3
case_images: The CEA level was low (<1.0 mug/L), but a thoracoabdominal CT scan demonstrated multiple focal liver lesions suspicious for metastatic disease (Figure 3).
case_images: The lesions were isointense in T1-weighted images and hyperintense in T2-weighted images and did not demonstrate any diffusion restriction.
case_images: CRIS2021-6676109.004.jpg
case_images: PMC8046561_02_CRIS2021-6676109.004.jpg
case_images: fig4
case_images: Liver MRI with and without gadoxetate sodium was performed (Figure 4).